News EPFL

Smart energy to power refugee camps

Published:21.08.13 — SERIE D'ÉTÉ (8): Rolling out renewable and smart energy solutions in refugee camps could dramatically improve the well being of millions of refugees world-wide. Working in collaboration with the UNHCR, an EPFL Master’s student is investigating how it could be done.

EPFL scientists find way to predict and control gene expression

Published:19.08.13 — EPFL scientists have developed a “guide” that can be used to precisely predict the number of proteins a given gene will produce under varying conditions. This work will help biologists to engineer cells.

Cancer: unraveling a mechanism behind cellular proliferation

Published:14.08.13 — A hallmark of cancer is uncontrolled and sustained cell division. One particular overactive protein is implicated in this malfunction. EPFL scientists have discovered a complex mechanism that regulates this protein’s activity in healthy cells.

The Robot and Its Virtual Twin

Published:12.08.13 — SUMMER SERIES (7): The work of David Mansolino, a graduate student in microtechnology, makes it possible for a small Korean robot with big eyes that change color to come to life through a virtual platform.

A software to guide your way through the symposium maze

Published:07.08.13 — SUMMER SERIES (6) Three students have created a new software application, TrailHead, which allows users to sort through (possibly hundreds of) symposium presentation abstracts and create a personalized schedule that matches their scientific interests. The software application could also prove useful with major film or music festivals, where choosing from among the dozens of different possibilities can be quite a challenge.

Researchers Dismantle Bacteria's War Machinery

Published:05.08.13 — A nano-machine cell killer: EPFL researchers decipher the attack strategy of certain bacteria, including the infamous Staphylococcus aureus.

New drugs to find the right target to fight Alzheimer's disease

Published:02.08.13 — Next-generation drugs designed to fight Alzheimer’s disease look very promising. Scientists have unveiled the mechanisms behind two classes of compound currently being tested in clinical trials. They have also identified a likely cause of early-onset hereditary forms of the disease.